Incidence and survival differences in esophageal cancer among ethnic groups in the United States

被引:44
作者
Chen, Zheling [1 ]
Ren, Yinghong [2 ]
Du, Xianglin L. [3 ]
Yang, Jiao [1 ]
Shen, Yanwei [1 ]
Li, Shuting [1 ]
Wu, Yunying [1 ]
Lv, Meng [1 ]
Dong, Danfeng [1 ]
Li, Enxiao [1 ]
Li, Wei [4 ]
Liu, Peijun [5 ]
Yang, Jin [1 ]
Yi, Min [1 ,6 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Shaanxi, Peoples R China
[2] Shangluo Cent Hosp, Dept Internal Med, Shangluo, Shaanxi, Peoples R China
[3] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA
[4] Weapon Ind Hlth Res Inst, Xian, Shaanxi, Peoples R China
[5] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Translat Med, Xian, Shaanxi, Peoples R China
[6] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA
关键词
esophageal cancer; the united states; survival; incidence rate; ethnicity; SQUAMOUS-CELL CARCINOMA; ADENOCARCINOMA INCIDENCE; RACIAL DISPARITIES; RISK; POPULATION; TRENDS; MORTALITY; EXPRESSION; PATTERNS; INCREASE;
D O I
10.18632/oncotarget.16694
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: This study was performed to identify the differences in incidence, clinicopathological features, and survival in esophageal cancer among ethnic groups in the United States and to determine the reasons for the differences. Result: A total of 49,766 patients were included. Black and Asian groups had a higher proportion of squamous cell carcinoma (ESCC) (85.5% and 75.4%, respectively) and mid-esophagus tumor (43.2% and 37.7% respectively) than the non-Hispanic white and Hispanic white groups. The incidences of ESCC in all ethnic groups declined since 1973, especially in black males. At the same time, incidences of esophageal adenocarcinoma (EAC) dramatically increased in white males since 1973. And incidences of ESCC and EAC were the lowest and stable in Asian female. Multivariable models showed that patients who were male, or black, or had larger tumors, or positive lymph nodes had an increased risk of death from esophageal cancer, while patients with ESCC or diagnosed after 2005 or treated with surgery had a lower likelihood of death. For ESCC, the black patients had the lowest DSS, while for EAC there were no significant differences in DSS among the ethnic/racial groups. Materials and Method: From the Surveillance, Epidemiology, and End Results Program database, patients diagnosed with esophageal cancer from 1998-2013 were identified. Differences in incidences, clinicopathological features, treatments, and disease-specific survival (DSS) in four broad racial/ethnic groups were compared. Conclusion: Histological type distribution between racial groups could be an important consideration in the incidence and the survival trend but other factors could also have an effect.
引用
收藏
页码:47037 / 47051
页数:15
相关论文
共 51 条
[11]   CYP3A5 genotypes and risk of oesophageal cancer in two South African populations [J].
Dandara, C ;
Ballo, R ;
Parker, MI .
CANCER LETTERS, 2005, 225 (02) :275-282
[12]   p16 hypermethylation: A biomarker for increased esophageal cancer susceptibility in high incidence region of North East India [J].
Das, Mandakini ;
Saikia, Bhaskar Jyoti ;
Sharma, Santanu Kumar ;
Sekhon, Gaganpreet Singh ;
Mahanta, Jagadish ;
Phukan, Rup Kumar .
TUMOR BIOLOGY, 2015, 36 (03) :1627-1642
[13]   Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma [J].
de Martel, C ;
Llosa, AE ;
Farr, SM ;
Friedman, GD ;
Vogelman, JH ;
Orentreich, N ;
Corley, DA ;
Parsonnet, J .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05) :761-767
[14]   Does the Incidence of Adenocarcinoma of the Esophagus and Gastric Cardia Continue to Rise in the Twenty-First Century?-a SEER Database Analysis [J].
Dubecz, A. ;
Solymosi, N. ;
Stadlhuber, R. J. ;
Schweigert, M. ;
Stein, H. J. ;
Peters, J. H. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (01) :124-129
[15]   Should every region use the same gastric cancer scanning and treatment approaches? let's reconsider: a northeastern turkey example [J].
Fatih, Albayrak ;
Yasin, Ozturk ;
Hakan, Dursun ;
Yavuz, Albayrak .
BMC GASTROENTEROLOGY, 2016, 16
[16]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[17]   Gastrointestinal Malignancies: When Does Race Matter? [J].
Fitzgerald, Timothy L. ;
Bradley, Cathy J. ;
Dahman, Bassam ;
Zervos, Emmanuel E. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (05) :645-652
[18]   Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial [J].
Ford, Hugo E. R. ;
Marshall, Andrea ;
Bridgewater, John A. ;
Janowitz, Tobias ;
Coxon, Fareeda Y. ;
Wadsley, Jonathan ;
Mansoor, Wasat ;
Fyfe, David ;
Madhusudan, Srinivasan ;
Middleton, Gary W. ;
Swinson, Daniel ;
Falk, Stephen ;
Chau, Ian ;
Cunningham, David ;
Kareclas, Paula ;
Cook, Natalie ;
Blazeby, Jane M. ;
Dunn, Janet A. .
LANCET ONCOLOGY, 2014, 15 (01) :78-86
[19]   Cervical esophageal cancer: A population-based study [J].
Grass, G. Daniel ;
Cooper, S. Lewis ;
Armeson, Kent ;
Garrett-Mayer, Elizabeth ;
Sharma, Anand .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (06) :808-814
[20]   Worldwide incidence, mortality and time trends for cancer of the oesophagus [J].
Gupta, Bhawna ;
Kumar, Narinder .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (02) :107-118